BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12674509)

  • 1. Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver.
    Carvalheira JB; Ribeiro EB; Folli F; Velloso LA; Saad MJ
    Biol Chem; 2003 Jan; 384(1):151-9. PubMed ID: 12674509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus.
    Carvalheira JB; Torsoni MA; Ueno M; Amaral ME; Araújo EP; Velloso LA; Gontijo JA; Saad MJ
    Obes Res; 2005 Jan; 13(1):48-57. PubMed ID: 15761162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway.
    Amaral ME; Ueno M; Carvalheira JB; Carneiro EM; Velloso LA; Saad MJ; Boschero AC
    Horm Metab Res; 2003 May; 35(5):282-9. PubMed ID: 12915997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
    Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
    Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin.
    Kim YB; Uotani S; Pierroz DD; Flier JS; Kahn BB
    Endocrinology; 2000 Jul; 141(7):2328-39. PubMed ID: 10875232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatidylinositol/AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo.
    Campbell CS; Caperuto LC; Hirata AE; Araujo EP; Velloso LA; Saad MJ; Carvalho CR
    Life Sci; 2004 Nov; 76(1):57-70. PubMed ID: 15501480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
    Johansen T; Laurino C; Barreca A; Malmlöf K
    Growth Horm IGF Res; 2005 Feb; 15(1):55-63. PubMed ID: 15701573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
    Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
    J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.
    Aytug S; Reich D; Sapiro LE; Bernstein D; Begum N
    Hepatology; 2003 Dec; 38(6):1384-92. PubMed ID: 14647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
    Carvalheira JB; Calegari VC; Zecchin HG; Nadruz W; Guimarães RB; Ribeiro EB; Franchini KG; Velloso LA; Saad MJ
    Endocrinology; 2003 Dec; 144(12):5604-14. PubMed ID: 12960006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
    Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity on insulin signaling through JAK2 in rat aorta.
    Gottardello Zecchin H; De Souza CT; Oliveira Prada P; Campello Carvalheira JB; Augusto Velloso L; Abdalla Saad MJ
    Vascul Pharmacol; 2005 Nov; 43(5):346-52. PubMed ID: 16236556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus.
    Benomar Y; Wetzler S; Larue-Achagiotis C; Djiane J; Tomé D; Taouis M
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):59-66. PubMed ID: 16150536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cardiac Jak-2 in animal models of insulin resistance.
    Rojas FA; Carvalho CR; Paez-Espinosa V; Saad MJ
    IUBMB Life; 2000 Jun; 49(6):501-9. PubMed ID: 11032244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the insulin and angiotensin signaling systems.
    Velloso LA; Folli F; Sun XJ; White MF; Saad MJ; Kahn CR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12490-5. PubMed ID: 8901609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1999 Feb; 13(2):213-27. PubMed ID: 9973252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway.
    Mansour E; Pereira FG; Araújo EP; Amaral ME; Morari J; Ferraroni NR; Ferreira DS; Lorand-Metze I; Velloso LA
    Endocrinology; 2006 Nov; 147(11):5470-9. PubMed ID: 16873541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.